GB2039916A - Protein synthesis by genetic manipulation - Google Patents

Protein synthesis by genetic manipulation Download PDF

Info

Publication number
GB2039916A
GB2039916A GB8001106A GB8001106A GB2039916A GB 2039916 A GB2039916 A GB 2039916A GB 8001106 A GB8001106 A GB 8001106A GB 8001106 A GB8001106 A GB 8001106A GB 2039916 A GB2039916 A GB 2039916A
Authority
GB
United Kingdom
Prior art keywords
gene
site
prokaryotic
bacteria
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB8001106A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of GB2039916A publication Critical patent/GB2039916A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • C12N15/72Expression systems using regulatory sequences derived from the lac-operon
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A process to produce specific proteins coded for by eukaryotic (or prokaryotic) DNA in bacteria. The process which uses recombinant DNA techniques, produces proteins in their natural, functional state unencumbered by extraneous peptides.

Description

SPECIFICATION Protein synthesis This invention is a method for producing in bacteria prokaryotic or eukaryotic proteins in native, unfused form free from extraneous peptides.
Recombinant DNA techniques in vitro have been used to insert a variety of eukaryotic genes into plasmids carried by Escherichia coli in an effort to induce these bacteria to produce eukaryotic proteins. Most of these genes have not directed the synthesis of the native proteins because the eukaryotic signals coding for initiation of transcription and/or translation do not function well in E. coli. One proposed solution to this problem has been the fusion of the eukaryotic gene with a bacterial gene.
The process results in the production of a hybrid protein, a portion of which at its carboxyl terminus is constituted by the eukaryotic protein. In one case, it has been possible to separate a small biologically active protein from a fusion product (Itakura, K. et al., Science 198, 1056 (1977)).
Gene expression takes place by transcription into mRNA then translation into protein. To do these operations, the DNA preceding the gene must have a sequence which: (a) directs efficient binding of bacterial RNA polymerase and efficient initiation of transcription, and (B) codes for a mRNA that directs efficient binding of mRNA to the ribosomes and initiation of translation into protein.
The present invention provides a method of producing native, unfused prokaryotic or eukaryotic protein in bacteria which comprises inserting into a bacterial plasmid a gene for a prokaryotic or eukaryotic protein and a portable promotor consisting of a DNA fragment containing a transcription initiation site recognized by RNA polymerase and containing no protein translation start site, said promotor being inserted ahead of a protein translational start site of said gene to form a fused gene having a hybrid ribosome binding site, inserting said plasmid into said bacteria to transform said bacteria with said plasmid containing said fused gene, and culturing the transformed bacteria to produce said prokaryotic or eukaryotic protein.
The present invention utilizes nucleases, restriction enzymes, and DNA ligase to position a portable promoter consisting of a DNA fragment containing a transcription site but no translation initiation site nearthe beginning ofthe gene which codesforthe desired protein to form a hybrid ribosomal binding site. The protein produced by the bacterium from this hybrid is the native derivative of the implanted gene. It has been found that the endonuclease digestion product of the E. colt lay operon, a fragment of DNA which contains a transcription initiation site but no translational start site, has the required properties to function as a portable promoter in the present invention, being transcribed at high efficiency by bacterial RNA polymerase.The mRNA produced contains a ribosomal binding site (Shine-Dalgerno (S-D) Sequence) but it does not include the AUG or GUG required for translational initiation. However, in accordance with the present invention, a hybrid is formed consisting of the S-D sequence and initiator from the lac operon and the AUG sequence of the gene, and such a fused gene is translated and transcribed efficiently. Using the enzymes exonuclease Ill and So, the promotor may be put at any desired position in front of the translational start site of the gene in order to obtain optimum production of protein.Since the promotor can be inserted at a restriction site ahead of the translational start site of the gene, the gene can first be cut at the restriction site, the desired number of base pairs and any single stranded tails can be removed by treating with nucleases for the appropriate time period, and religating.
The following specific example is intended to illustrate more fully the nature of the present invention without acting as a limitation upon its scope.
Example A rabbit P-globin gene was first cloned into the Hin Ill site of pBR322, a plasmid of the E. coli bacteria, via restriction enzyme cuts of the initial DNA, reconstitution of the gene by T4 ligase, insertion of the reconstituted gene into the Hin Ill site using chemically synthesized Hin Ill linkers, and religating with DNA ligase.
The Hin Ill cut at the carboxyl end of the cloned gene was removed by partialiy digesting with Hin III, filling in the resulting Hin III "sticky ends" with E. coli DNA polymerase I, and religating with T4 ligase. This left in the resulting plasmid a single Hin III cut 25 base pairs ahead of the amino terminus of the globin gene.
Differing numbers of the 25 base pairs between the Hin III cut and the ATG signalling the start point of translation were removed from different samples of the cloned gene as follows: the plasmid was cut with Hin Ill, resected for various times from 0.5 to 10 minutes with Exo Ill, then treated with SI to remove single-stranded tails.
The portable promoter of the lac operon, an R1-Alu restriction fragment of E. coli DNA, was then inserted by treating each sample of the plasmid with RI which cuts at a unique site some 30 base pairs upstream from the Hin Ill site, and the portable promotor was inserted into the plasmid backbone at this site. This requires one "sticky end" and one "flush" end, both of which are ligated by the same treatment with ligase.
Colonies of E. coli each containing one of these resulting plasmids were then screened for (3-globin production using RIA-screening techniques to identify the one or more producing p-globin.
The globin gene in the above construction can be any gene coding for prokaryotic or eukaryotic proteins, and any other unique restriction site can be employed in place of the Hin Ill site. If the restriction site is located inconveniently far from the beginning of the gene, it may be moved (for example, a Hin Ill site may be moved by opening the plasmid with Hin Ill, digesting with Exo Ill and S1,then religating the resulting plasmid in the presence of excess Hin Ill linkers). Any suitable restriction site can be employed for insertion of the portable promotor in place of the R1 site (e.g. Pst, BAM, or Sal I). Finally, it should be emphasized that the most difficult step, the cloning of the gene into the plasmid, is done once and left unchanged. The promotor fragment will confer its constitutive expression on the cell so it is easy to screen for the intact promoters.

Claims (10)

1. A fused gene coding for a hybrid ribosome binding site comprising the region of a bacterial gene comprising, inorder of transcription, the SD region, and at least one base pair adjacent to said SD region, fused to the region of a gene for a prokaryotic or eukaryotic protein comprising, in order of transcription, at least one base pair adjacent to a translation start site, and said translation start site.
2. The fused gene of claim 1, further comprising ahead of said sd region, the promotor region of said bacterial gene, and after said translation start site of said gene for said prokaryotic or eukaryotic protein, the region of said gene coding for said prokaryotic or eukaryotic protein.
3. The method of producing native, unfused prokaryotic or eukaryotic protein in bacteria which comprises inserting into a bacterial plasmid a gene for a prokaryotic or eukaryotic protein and a portable promotor consisting of a DNA fragment containing a transcription initiation site recognized by RNA polymerase and containing no protein translational start site, said promoter being inserted ahead of a protein translational start site of said gene to form a fused gene having a hybrid ribosome binding site, inserting said plasmid into said bacteria to transform said bacteria with said plasmid containing said fused gene, and culturing the transformed bacteria to produce said prokaryotic or eukaryotic protein.
4. The method as claimed in claim 3 in which said bacteria is E. coli.
5. The method as claimed in claims 3 or 4 in which said portable promotor is the product of restriction endonuclease digestion of an operon.
6. The method claimed in claim 4 in which said portable promotor is the product of restriction endonuclease digestion ofthelacoperon of E. coli.
7. The method as claimed in claims 3 or 4 in which said gene insertion comprises cloning said gene into said plasmid, adjusting the spacing between said inserted gene and a preceding unique restriction site by treating with a nuclease, and cloning said portable promotor into said restriction site.
8. The method as claimed in claim 4 in which said gene insertion comprises cloning said gene into said plasmid, adjusting the spacing between said gene and a preceding unique restriction site by treating with a nuclease, and cloning into said restriction site a portable promoter formed by the endonuclease digestion ofthelacoperon of E. coli.
9. A fused gene coding for a hybrid ribosome site substantially as hereinbefore described with reference to the Example.
10. A method of producing native, unfused prokaryotic or eukaryotic protein in bacteria substantially as hereinbefore described with reference to the < Example.
GB8001106A 1979-01-15 1980-01-14 Protein synthesis by genetic manipulation Withdrawn GB2039916A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US310279A 1979-01-15 1979-01-15

Publications (1)

Publication Number Publication Date
GB2039916A true GB2039916A (en) 1980-08-20

Family

ID=21704160

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8001106A Withdrawn GB2039916A (en) 1979-01-15 1980-01-14 Protein synthesis by genetic manipulation

Country Status (7)

Country Link
JP (1) JPS5599193A (en)
CA (1) CA1174617A (en)
DE (1) DE3000982A1 (en)
FR (1) FR2446318A1 (en)
GB (1) GB2039916A (en)
NL (1) NL8000127A (en)
SE (1) SE8000297L (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063494A2 (en) * 1981-04-20 1982-10-27 Cetus Corporation Method for producing protein from a microorganism, microorganisms for use in such method and creation thereof, vectors for use in said creation, and protein produced thereby, and transformant culture derived from said microorganisms
WO1985003522A1 (en) * 1984-02-08 1985-08-15 Cetus Corporation Monitoring and control systems for recombinant manipulations
US4874702A (en) * 1980-09-08 1989-10-17 Biogen, Inc. Vectors and methods for making such vectors and for expressive cloned genes
US5860189A (en) * 1997-03-06 1999-01-19 An; Tae-Heup Door wheel
US7588755B1 (en) 1980-04-03 2009-09-15 Biogen Idec Ma Inc. DNA sequences, recombinant DNA molecules and processes for producing human fibroblast interferon-like polypeptides

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2071671B (en) * 1980-03-17 1983-10-05 Harvard College Polypeptide production
US4582800A (en) * 1982-07-12 1986-04-15 Hoffmann-La Roche Inc. Novel vectors and method for controlling interferon expression
JPS5965099A (en) * 1982-10-05 1984-04-13 Takeda Chem Ind Ltd Promoter for expression and its use

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7588755B1 (en) 1980-04-03 2009-09-15 Biogen Idec Ma Inc. DNA sequences, recombinant DNA molecules and processes for producing human fibroblast interferon-like polypeptides
US7635466B1 (en) 1980-04-03 2009-12-22 Biogen Idec Ma Inc. DNA sequences, recombinant DNA molecules and processes for producing human fibroblast interferon-like polypeptides
US4874702A (en) * 1980-09-08 1989-10-17 Biogen, Inc. Vectors and methods for making such vectors and for expressive cloned genes
EP0063494A2 (en) * 1981-04-20 1982-10-27 Cetus Corporation Method for producing protein from a microorganism, microorganisms for use in such method and creation thereof, vectors for use in said creation, and protein produced thereby, and transformant culture derived from said microorganisms
EP0063494A3 (en) * 1981-04-20 1984-02-22 Cetus Corporation Method for producing protein from a microorganism, microorganisms for use in such method and creation thereof, vectors for use in said creation, and protein produced thereby, and transformant culture derived from said microorganisms
WO1985003522A1 (en) * 1984-02-08 1985-08-15 Cetus Corporation Monitoring and control systems for recombinant manipulations
US5860189A (en) * 1997-03-06 1999-01-19 An; Tae-Heup Door wheel

Also Published As

Publication number Publication date
CA1174617A (en) 1984-09-18
DE3000982A1 (en) 1980-08-07
SE8000297L (en) 1980-09-08
NL8000127A (en) 1980-07-17
FR2446318A1 (en) 1980-08-08
JPS5599193A (en) 1980-07-28

Similar Documents

Publication Publication Date Title
US4332892A (en) Protein synthesis
US4418149A (en) Fused hybrid gene
EP0267851B1 (en) Hybrid promoter, expression controlling DNA sequence and expression vector
US4536475A (en) Plant vector
CA1318867C (en) Plasmid expression vector for use in escherichia coli
KR860001230B1 (en) Cutting method of double stranded dna
KR870000701B1 (en) The human growth hormone preparing method
Genilloud et al. The transposon Tn5 carries a bleomycin-resistance determinant
US4711845A (en) Portable temperature-sensitive control cassette
Kodaira et al. The dnaX gene encodes the DNA polymerase III holoenzyme τ subunit, precursor of the γ subunit, the dnaZ gene product
GB2073245A (en) Production of Bovine Growth Hormone by Microorganisms
CA1210347A (en) Microbial hybrid promotors
CA1174617A (en) Protein synthesis
EP0054330B1 (en) Dna sequences encoding various allelic forms of mature thaumatin, recombinant plasmids comprising said dna&#39;s and a process for their preparation, bacterial cultures comprising said recombinant plasmids, and method for producing mature thaumatin
US4649119A (en) Cloning systems for corynebacterium
CA1193207A (en) Structural genes encoding the various allelic maturation forms of preprothaumatin, recombinant cloning vehicles, comprising said structural genes and expression thereof in transformed microbial host cells
EP0321940B1 (en) An improved method for the preparation of natural human growth hormone in pure form
JPH10505746A (en) Process for producing recombinant proteins, plasmids and modified cells
ATE161049T1 (en) METHOD AND NUCLEIC ACID SEQUENCES FOR EXPRESSING THE CELLULOSE SYNTHASE OPERON
Stuitje et al. The nucleotide sequence surrounding the replication origin of the cop3 mutant of the bacterio-cinogenic plasmid Clo DF13
IE53607B1 (en) Expression vectors
JP2561674B2 (en) Method of producing protein
EP0109428B1 (en) Cloning vector with indicator genes which have been inactivated by frameshift
WO1984000380A1 (en) Vector
EP0314184B1 (en) Expression plasmids

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)